DILTIAZEM AND METOCLOPRAMIDE OVERDOSE

被引:10
作者
BENO, JM
NEMETH, DR
机构
关键词
D O I
10.1093/jat/15.5.285
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A fatality resulting from the suicidal ingestion of diltiazem and metoclopramide is described. The decedent was a 25-year-old female with a history of alcoholism and cocaine abuse who overdosed on her mother's medications. On admission she was bradycardic with severe hypotension and third-degree heart block which progressed to asystole. She was resuscitated but remained comatose until her death four days later. Serum samples from the first 15 h of hospitalization were analyzed for diltiazem and metoclopramide by gas chromatography with nitrogen-phosphorus detection. Diltiazem levels 1 hour post admission were 8.49 mg/L. Diltiazem elimination followed zero-order kinetics with an elimination rate of 0.68 mg/L/h. Metoclopramide levels 1 hour post admission were 4.40 mg/L. Data indicated a biphasic elimination curve for metoclopramide with an initial half-life of 1.3 h and a terminal half-life of 20 h.
引用
收藏
页码:285 / 287
页数:3
相关论文
共 14 条
[1]   CLINICAL PHARMACOKINETICS OF METOCLOPRAMIDE [J].
BATEMAN, DN .
CLINICAL PHARMACOKINETICS, 1983, 8 (06) :523-529
[2]  
BENOWITZ N, 1990, CLIN MANAGEMENT POIS, pCH92
[3]  
BUFFET M, 1984, PRESSE MED, V13, P1338
[4]   PHARMACOKINETICS AND TOXIC EFFECTS OF DILTIAZEM IN MASSIVE OVERDOSE [J].
FERNER, RE ;
ODEMUYIWA, O ;
FIELD, AB ;
WALKER, S ;
VOLANS, GN ;
BATEMAN, DN .
HUMAN TOXICOLOGY, 1989, 8 (06) :497-499
[5]   EFFECT OF DILTIAZEM OVERDOSE [J].
JAKUBOWSKI, AT ;
MIZGALA, HF .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (10) :932-933
[6]   MASSIVE DILTIAZEM OVERDOSAGE - CLINICAL AND PHARMACOKINETIC OBSERVATIONS [J].
MALCOLM, N ;
CALLEGARI, P ;
GOLDBERG, J ;
STRAUSS, H ;
CAILLE, G ;
VEZINA, M ;
SPENARD, J .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (11) :888-888
[7]   PHARMACOKINETICS OF HIGH-DOSE METOCLOPRAMIDE IN CANCER-PATIENTS [J].
MCGOVERN, EM ;
GREVEL, J ;
BRYSON, SM .
CLINICAL PHARMACOKINETICS, 1986, 11 (06) :415-424
[8]   METOCLOPRAMIDE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE [J].
PINDER, RM ;
BROGDEN, RN ;
SAWYER, PR ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1976, 12 (02) :81-131
[9]  
POLLERA C, 1984, LANCET, P460
[10]  
REASBECK PG, 1979, BRIT J CLIN PRACT, V33, P31